drugset / Trial / NCT01961505

Topical Compound Tripterygium Wilfordii Hook F for Patients With Active Rheumatoid Arthritis

NCT01961505 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

Rheumatoid Arthritis (RA) is an autoimmune disease that results in a chronic inflammatory disorder that may affect many synovial joints, and may cause serious disability. It has been confirmed that Tripterygium wilfordii Hook F has effects of anti-inflammatory, immunosuppressive and cartilage protection. This is a prospective randomized controlled study to evaluated the efficacy and safety of external application with compound Tripterygium wilfordii Hook F in treating of patients with rheumatoid arthritis (RA).

Timeline

Start
2011-10
Primary completion
2015-09
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject compound tripterygium Unknown 3 ml Topical
Subject compound tripterygium Unknown 5 ml Topical
Subject compound tripterygium Unknown 10 ml Topical

Indications